New York State Common Retirement Fund’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
QPW
AWM
HWAM
AA
CPIG
New York State Common Retirement Fund's TSHA Position: Q2 2026 in Review
New York State Common Retirement Fund increased its Taysha Gene Therapies (TSHA) stake by 2.7% in Q2 2026, buying an estimated $10.7K and bringing the position to 69,300 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.
New York State Common Retirement Fund first reported a position in TSHA in Q4 2020 and has held it in 16 quarters since. 46 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.
- New York State Common Retirement Fund held 69,300 shares of Taysha Gene Therapies worth $472K as of Q2 2026.
- New York State Common Retirement Fund bought 1,800 Taysha Gene Therapies shares in Q2 2026, an estimated $10.7K.
- Taysha Gene Therapies made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2021 holding.
- New York State Common Retirement Fund first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 16 quarters since.
- 46 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.